| | 670220-88-9 Basic information More.. |
| Product Name: | Crenolanib | | Synonyms: | Crenolanib, >=98%;Crenolanib;[1-[2-[5-(3-Methyloxetan-3-ylMethoxy)benziMidazol-1-yl]quinolin-8-yl]piperidin-4-yl]aMine;1-[2-[5-[(3-Methyl-3-oxetanyl)Methoxy]-1H-benziMidazol-1-yl]-8-quinolinyl]-4-piperidinaMine;ARO 002;CP 868596;Crenolanib (CP-868569);Crenolanib (CP-868596) | | CAS: | 670220-88-9 | | MF: | C26H29N5O2 | | MW: | 443.54 | | EINECS: | | | Mol File: | 670220-88-9.mol |  |
Use
Crenolanib (CP-868569) is a tyrosine kinase inhibitor that acts by specifically inhibiting the receptor tyrosine kinases PDGFRα and PDGFRβ. Crenolanib (CP-868569) inhibits the activity of PDGFRα D842V kinase and prevented the phosphorylation of wild type PDGFRα. Crenolanib (CP-868569) possesses potential antineoplastic activity. Crenolanib is believed to suppress PDGFR-related signal transduction pathways leading to the inhibition of tumor angiogenesis and tumor cell proliferation.
- Crenolanib
-
- US $7.00 / KG
- 2019-07-06
- CAS: 670220-88-9
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100KG
|
|
670220-88-9
Recommend Suppliers |
|